Nomura Holdings
ABOS icon

Nomura Holdings’s Acumen Pharmaceuticals ABOS Stock Holding History

Nomura Holdings’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Buy
+189,712
New +$469K ﹤0.01% 1511

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Nomura Holdings's ABOS Position: Q2 2026 in Review

Nomura Holdings opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 189,712 shares worth $507K. The stake represents ﹤0.01% of the portfolio and ranks #1511 among its holdings.

96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Nomura Holdings held 189,712 shares of Acumen Pharmaceuticals worth $507K as of Q2 2026.
  • Acumen Pharmaceuticals was a new Nomura Holdings position in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1511 holding.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.